Genprex Other Stockholder Equity from 2010 to 2024

GNPX Stock  USD 1.09  0.01  0.91%   
Genprex Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity will likely drop to about 73.6 M in 2024. During the period from 2010 to 2024, Genprex Other Stockholder Equity regression line of annual values had r-squared of  0.72 and arithmetic mean of  48,502,525. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2016-12-31
Previous Quarter
150.5 M
Current Value
152.1 M
Quarterly Volatility
48.5 M
 
Covid
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Interest Expense of 21.9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.61. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
  
Check out the analysis of Genprex Correlation against competitors.
For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Latest Genprex's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Genprex over the last few years. It is Genprex's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genprex's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Genprex Other Stockholder Equity Regression Statistics

Arithmetic Mean48,502,525
Geometric Mean28,937,387
Coefficient Of Variation99.69
Mean Deviation40,910,847
Median17,869,205
Standard Deviation48,350,264
Sample Variance2337.7T
Range130.7M
R-Value0.85
Mean Square Error709.8T
R-Squared0.72
Significance0.000067
Slope9,161,466
Total Sum of Squares32728.5T

Genprex Other Stockholder Equity History

202473.6 M
2023141.1 M
2022125.1 M
2021120.3 M
202089.3 M
201943.5 M
201838.7 M

About Genprex Financial Statements

Genprex investors use historical fundamental indicators, such as Genprex's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genprex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity141.1 M73.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.